The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Woods, S. W.
* Articles by Cohen, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Woods, S. W.
* Articles by Cohen, J.
Related Collections
* Biostatistics
Am J Psychiatry 155:1446-1448, October 1998
©Copyright 1998 American Psychiatric Association


Brief Report

Efficient Allocation of Patients to Treatment Cells in Clinical Trials With More Than Two Treatment Conditions

Scott W. Woods, M.D., Diane E. Sholomskas, Ph.D., M. Katherine Shear, M.D., Jack M. Gorman, M.D., David H. Barlow, Ph.D., Andrew W. Goddard, M.D., and Jacob Cohen, Ph.D.

Objective:Clinical trials generally allocate patients to equal-sized treatment groups. The authors propose that it may be more efficient to allocate unequal proportions of the total sample size to treatments when more than two treatments are being compared. Method:This proposal is illustrated with two examples. One involved a comparison of three treatments and used a dichotomous categorical outcome. The other involved comparison of three treatments and used a continuous measure.Results:In both examples, a considerable increase in efficiency was realized by reducing the number of patients assigned to the placebo cell.Conclusions:Unequal allocation of patients to treatments should be considered when more than two groups are compared. Am J Psychiatry 1998; 155: 1446-1448




This article has been cited by other articles:


Home page
NeurologyHome page
J. A. Haythornthwaite
Clinical trials studying pharmacotherapy and psychological treatments alone and together
Neurology, December 29, 2005; 65(12_suppl_4): S20 - S31.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. S. Charney, C. B. Nemeroff, L. Lewis, S. K. Laden, J. M. Gorman, E. M. Laska, M. Borenstein, C. L. Bowden, A. Caplan, G. J. Emslie, et al.
National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Arch Gen Psychiatry, March 1, 2002; 59(3): 262 - 270.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. H. Barlow, J. M. Gorman, M. K. Shear, and S. W. Woods
Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial
JAMA, May 17, 2000; 283(19): 2529 - 2536.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org